LifeSpanDx Launches the Foundation Program—A New Era of Preventive Health

DALLAS - Feb. 7, 2026 - PRLog -- LifeSpanDx today announced the official launch of the LifeSpanDx Foundation Program, a breakthrough preventive health initiative designed to redefine how individuals understand, monitor, and protect their long-term health. For less than $1.50 per day, the program provides comprehensive testing of more than 165 critical longevity and disease-risk biomarkers, performed three times annually—bringing precision diagnostics once reserved for elite medicine to everyone.

In a healthcare system traditionally focused on treating illness after it appears, LifeSpanDx shifts the paradigm toward early detection, continuous insight, and proactive longevity care.

"Health should never be reactive. It should be predicted, protected, and personalized," said Nida Fatima, MD, Founder and CEO of LifeSpanDx and Filos Health Laboratory. "The Foundation Program is our commitment to making advanced longevity science accessible—so every individual has the power to understand their biology before disease begins."

A Preventive Health Platform Built for the Future of Medicine

The LifeSpanDx Foundation Program combines:

• 165+ clinically significant biomarkers spanning metabolic, cardiovascular, hormonal, inflammatory, immune, renal, hepatic, and longevity pathways
• Testing three times per year to track trends—not just single moments in time
• AI-driven clinical insight translating complex lab data into meaningful health predictions
• Actionable reporting designed for patients, physicians, and precision-medicine optimization
• Accessible pricing at under $1.50/day, democratizing elite preventive care

This data-driven approach enables earlier risk detection, personalized intervention, and measurable health optimization—key pillars in extending both lifespan and healthspan.

Meeting the Global Shift Toward Longevity Medicine

Demand for preventive diagnostics and longevity science is accelerating worldwide. Yet access remains limited by cost, complexity, and fragmented care models.

LifeSpanDx addresses this gap with a scalable, mobile-first, precision diagnostic platform built on the clinical and technological foundation of Filos Health Laboratory, a CLIA- and COLA-accredited diagnostic leader serving tens of thousands of patients annually.

By integrating advanced laboratory science, artificial intelligence, and preventive medicine, LifeSpanDx positions itself at the forefront of the next generation of healthcare—predictive, personalized, and proactive.

Availability

The LifeSpanDx Foundation Program is now open for enrollment in select U.S. regions, with national expansion underway.

To learn more or begin your preventive health journey, visit:
www.filoshealthlab.com/lifespandx

About LifeSpanDx

LifeSpanDx is a precision longevity diagnostics company dedicated to transforming healthcare from reactive treatment to predictive prevention. Built on advanced clinical laboratory infrastructure and AI-powered analytics, LifeSpanDx delivers continuous biological insight that empowers individuals and physicians to optimize health, reduce disease risk, and extend quality of life.

Learn more: https://filoshealthlab.com